Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-17

Clinical Trial Update: Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for TBI [Phase 1]

View source ↗

Summary

This Clinical Trial Update describes a Phase 1 safety study of intravenously infused cultured allogeneic umbilical cord-derived mesenchymal stem cells for traum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cultured allogeneic umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: The Foundation for Orthopaedics and Regenerative Medicine | Conditions: Traumatic Brain Injury | Phase 1 | Status: NOT_YET_RECRUITING